10 Ayurvedic drinks that help control blood sugar levels
Tired of too many ads? go ad free now
Suggested by centuries of use and modern research, drinks infused with ingredients like cinnamon, fenugreek, turmeric, and bitter gourd are known to improve insulin sensitivity, aid digestion, and reduce sugar cravings. These time-tested beverages not only help maintain sugar balance but also promote overall well-being, making them a gentle yet effective part of diabetes care in Ayurveda.
10 Ayurvedic drinks to control sugar
Water
Water is the best drink for managing blood sugar.
It helps flush out excess glucose through urine and keeps your body hydrated, which supports your metabolism. If you want to go for an added flavour without raising sugar, you can infuse it with lemon or cucumber. Try to drink at least 8 to 10 glasses of water daily to stay well-hydrated and support blood sugar balance.
Green Tea
Green tea is rich in antioxidants called catechins, which may improve insulin sensitivity and help reduce blood sugar levels.
It's best to enjoy it plain, without adding sugar, honey, or milk. You should have one to two cups per day, mainly between meals or in the morning, to get the full benefit.
Cinnamon Tea
Cinnamon may help lower fasting blood sugar and improve insulin resistance; drinking it as a tea is an easy, sugar-free way to include it in your routine. The process is too quick; boil a cinnamon stick in water for 10 minutes and drink it warm. A small cup daily, preferably in the morning, can be a good addition to your routine.
Tired of too many ads? go ad free now
Apple Cider Vinegar Drink
Apple cider vinegar may help reduce blood sugar, especially after meals. However, it's important to dilute it—mix one tablespoon in a full glass of water as drinking it straight can damage teeth and irritate your stomach. If you are looking for the best results, drink it once a day before a meal, not more.
Bitter Gourd (Karela) Juice
Bitter gourd has insulin-like compounds that may help regulate blood sugar naturally. The taste is strong, so it's a good idea to start with small amounts—like ¼ to ½ a cup.
If you're having it two to three times a week, that's generally enough, but if you're on diabetes medication, talk to your doctor first.
Aloe Vera Juice
Aloe vera juice has been linked to lower fasting blood sugar and better insulin sensitivity. Make sure you use unsweetened, food-grade aloe vera juice, as many products have added sugars. Stick to about 50–100 ml a few times a week, and don't go overboard, as too much can cause stomach upset.
Fenugreek Water
Soaking fenugreek seeds overnight creates a fibre-rich water that may help slow sugar absorption and improve digestion. Just soak one tablespoon of seeds in water and drink the water first thing in the morning on an empty stomach. Having it daily can be an easy morning ritual to support blood sugar control.
Low-Glycaemic Vegetable Juice
Vegetable juices made with greens like spinach, cucumber, celery, and tomato are low in sugar and high in fibre, which helps with glucose regulation.
Avoid juicing high-sugar veggies like carrots and beets too often. One small glass of fresh juice daily, preferably without salt, is a smart addition to your routine.
Herbal Teas (Chamomile, Hibiscus)
Herbal teas like chamomile and hibiscus may help lower blood sugar and support heart health. Always choose unsweetened, caffeine-free varieties to avoid hidden sugars. One to two cups a day, especially in the evening, can offer both relaxation and blood sugar support.
Unsweetened plant-based milk
Unsweetened versions of almond, soy, or oat milk have fewer carbs than regular dairy milk and are less likely to spike blood sugar. Always check the label for added sugars, especially in flavoured versions. Use them as a milk alternative in your daily tea, coffee, or smoothies as needed.
Also Read:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Duty relief to boost pharma companies' access to UK drug stores
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel The India-UK FTA is expected to give a strong tailwind to India's pharmaceutical and medical devices sectors with tariff relief and smoother regulatory pathways acting as critical drivers, industry experts told agreement will boost exports giving an easier access to the UK market. It is expected to help Indian companies - especially those in generics and biosimilars - to scale their market presence, fast track product approvals, provide a push to cross-border R&D and UK has committed to zero tariff on nearly 99% of Indian pharma exports. While Indian pharma exports to the UK were largely duty free even earlier, the latest agreement formalises the status which brings in long-term clarity to to industry estimates, the pharma market size of the UK stands at about $45 billion and is expected to shoot to $73 billion by 2033. The share of the Indian drugs can see a significant push from the UK's generics segment which is currently pegged at $5 pharmaceutical exports to the UK crossed $910 million in FY24, according to estimates."The agreement strengthens supply chains , enhances access to affordable medicines , and drives Foreign Direct Investment (FDI)," said Namit Joshi, Chairman of Pharmexcil."This partnership paves the way for collaborations in bulk drug imports, CDMO (contract manufacturing), and joint research, empowering India's competitive edge and promoting global partnerships."The pact will open up trade and economic opportunities between the two countries. "The pharma sector will have opportunities to supply quality medicines contributing to better patient care in the UK," said Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance."The tariffs relief on generic medicines and key medical devices like surgical instruments and diagnostics under the FTA will enhance the affordability and appeal of Indian products in the UK market," said Manoj Mishra, Partner and Tax Controversy Management Leader, Grant Thornton Bharat. The move significantly boosts the competitiveness of Indian generics and high-quality affordable healthcare solutions, positioning India to scale its footprint in one of Europe's most valuable healthcare markets, said the medical devices sector too the move is expected to open new opportunities, said experts.
The Hindu
an hour ago
- The Hindu
Doctors stress the need for gender-neutral cervical cancer prevention strategy in India
For years, the human papillomavirus (HPV) vaccine has been closely associated with preventing cervical cancer in women. However, doctors are now pushing for a more inclusive approach, urging that boys too be vaccinated to curb transmission and protect against several other cancers linked to the virus. At the Conquer HPV and Cancer Conclave, an initiative by the Serum Institute of India in Hyderabad on Thursday, doctors underscored the need to reframe HPV as a public health concern rather than solely a women's health issue. 'Why boys? Because they are the carriers. HPV is primarily transmitted through sexual contact. In both Indian and Western statistics, about one in three boys are found to have the virus by the age of 15. While it may not cause immediate symptoms or health issues in boys, it is often passed on to girls, increasing their risk of cervical cancer,' said Dr. M. Surendranath, HoD, Paediatrics, DNB Faculty, Vijay Marie Hospital, Hyderabad. He pointed out that HPV is not limited to cervical cancer. 'It can also lead to penile cancer, anal cancer, and oropharyngeal (throat) cancer in men. Moreover, HPV types 6 and 11 cause genital warts, psychologically distressing, though not cancerous. Australia's decision to vaccinate boys under its national immunisation programme has significantly brought down cases of genital warts,' he said. Silent virus, late consequences One reason for the lack of awareness, doctors say, is that HPV doesn't show symptoms early on. 'It is unlike other viral infections where you get a fever or rash. In the case of HPV, most people don't even realise they've been infected. It can remain dormant in the body for decades and only manifest as cancer years later,' said Dr. D. Leela, consultant gynaecologist, St. Theresa's Hospital and Asvins Hospital, Hyderabad. Screening and prevention: Not just vaccines While vaccination is a crucial step in prevention, doctors highlighted the importance of screening, especially for women aged 30 and above. 'There are three levels of screening. The government-recommended method is VIA (Visual Inspection with Acetic Acid), where simple vinegar is applied to the cervix to check for abnormalities. Then there is the more familiar Pap smear or cytology. And finally, the most sensitive but costly option is the HPV DNA test, which detects the presence of the virus directly,' the doctor added. Vaccine targets and coverage The most commonly used HPV vaccines in India are quadrivalent, targeting types 6, 11, 16, and 18. While 6 and 11 are responsible for genital warts, 16 and 18 account for over 80% of cervical cancer cases. 'As far as genital warts go, they are relatively uncommon in India compared to Western countries. In our clinical experience, they account for about 5 to 10% of cases in gynaecological practice. Many of these patients go to dermatologists instead,' said Dr Surendranath.
Mint
3 hours ago
- Mint
India-UK FTA to boost bilateral trade for pharma, medtech, say industry bodies
The India-UK free trade agreement, signed on Thursday, is expected to open up new opportunities for Indian pharmaceutical and medical device makers. The deal is also expected to improve access to medical devices from the UK in India. Medical device manufacturers anticipate an increase in trade between the two countries but are awaiting clarity on non-tariff measures and on whether regulatory processes will be streamlined. 'Previously, medical devices imported into the UK were duty-free, so tariff restrictions were not an issue but regulatory approval costs and time were a challenge,' said Rajiv Nath, forum coordinator of industry body Association of Indian Medical Device Industry (Aimed). The body had previously sought recognition of regulatory approvals from the CDSCO or the Quality Council of India's voluntary Indian Certification for medical devices to fast-track approvals by the UK's Medicines and Healthcare products Regulatory Agency (MHRA). 'We look forward to an update on this,' said Nath. However, medtech manufacturers are also seeking strict monitoring of imports to India, to prevent other countries rerouting products into India through the UK. Mint had previously reported that domestic manufacturers raised concerns over the possibility of Chinese-origin products being routed through the UK to exploit the zero-tariff provisions under the FTA. India levies about 7.5% import duties on medical devices from the UK, which are expected to come down in a phased manner after the deal, Nath said. In 2024, medical device exports to the UK increased by 13% year-on-year to ₹ 1,015 crore, while imports from the UK rose 36% to ₹ 2,295 crore, according to Exim data. 'It not only strengthens trade ties but also opens new avenues for advanced technology collaborations between Indian and UK companies,' Himanshu Baid, managing director of Poly Medicure Ltd, said in a statement. 'With India exporting medical devices worth approximately $115 million to the UK, one of our top 10 export destinations, this agreement is poised to further boost our presence,' he added. The trade deal is also expected to open up the market for India's generic drugmakers. 'As per the indications, the pharma sector will have opportunities to supply affordable and quality assured medicine contributing to better patient care in the UK,' said Sudarshan Jain, secretary general of the Indian Pharmaceutical Alliance (IPA). 'We are awaiting further details to identify specific areas where these opportunities can be effectively leveraged,' he added. Generic players like Lupin, Biocon, Dr. Reddy's Laboratories and Wockhardt, which have exposure to the UK market, could stand to benefit.
